← Back to Testing, Diagnosis and Treatment
Health guidanceUnited Kingdom with regional context

What is two-tier Lyme disease testing?

Two-tier testing uses an initial antibody assay followed, when indicated, by a second confirmatory immunoblot or another assay under the applicable laboratory algorithm.

Reviewed by VuxLore® Knowledge Team For Everyone

Short answer

Two-tier testing uses an initial antibody assay followed, when indicated, by a second confirmatory immunoblot or another assay under the applicable laboratory algorithm.

At a glance

Two-tier testing uses an initial antibody assay followed, when indicated, by a second confirmatory immunoblot or another assay under the applicable laboratory algorithm. Test choice and interpretation depend on timing, symptoms, geography and validated laboratory pathways. A result should never be separated from its clinical context.

Key takeaways

• Two-tier testing uses an initial antibody assay followed, when indicated, by a second confirmatory immunoblot or another assay under the applicable laboratory algorithm.

• Test choice and interpretation depend on timing, symptoms, geography and validated laboratory pathways. A result should never be separated from its clinical context.

• This material is educational and cannot diagnose, exclude or treat illness. Use NHS 111, a GP, emergency services or the corresponding local service according to symptom severity.

Direct answer

Two-tier testing uses an initial antibody assay followed, when indicated, by a second confirmatory immunoblot or another assay under the applicable laboratory algorithm.

Why context matters

Test choice and interpretation depend on timing, symptoms, geography and validated laboratory pathways. A result should never be separated from its clinical context.

What to do next

This material is educational and cannot diagnose, exclude or treat illness. Use NHS 111, a GP, emergency services or the corresponding local service according to symptom severity.

Sources and further reading

UK Lyme disease guidance and data

For current UK clinical advice, public-health guidance and surveillance data, consult these primary national sources.

  1. Lyme disease — NHS opens in a new tab
  2. Lyme disease: diagnosis and management (NG95) — NICE opens in a new tab
  3. Lyme disease: management and prevention — UKHSA opens in a new tab
  4. Lyme disease surveillance dashboard — UKHSA opens in a new tab
  5. Lyme disease — NHS Inform Scotland opens in a new tab